DGX
Quest Diagnostics Inc
Price:  
149.00 
USD
Volume:  
678,835.00
United States | Health Care Providers & Services
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

DGX EV/EBITDA

13.4%
Upside

As of 2024-10-14, the EV/EBITDA ratio of Quest Diagnostics Inc (DGX) is 11.58. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. DGX's latest enterprise value is 20,737.68 mil USD. DGX's TTM EBITDA according to its financial statements is 1,791.00 mil USD. Dividing these 2 quantities gives us the above DGX EV/EBITDA ratio.

Range Selected
Trailing P/E multiples 10.5x - 13.3x 12.1x
Forward P/E multiples 11.6x - 16.7x 14.3x
Fair Price 131.32 - 217.52 169.01
Upside -11.9% - 46.0% 13.4%
149.00 USD
Stock Price
169.01 USD
Fair Price

DGX EV/EBITDA - Historical EV/EBITDA Data

Date EV/EBITDA
2024-10-14 11.58
2024-10-11 11.56
2024-10-10 11.50
2024-10-09 11.58
2024-10-08 11.57
2024-10-07 11.45
2024-10-04 11.69
2024-10-03 11.77
2024-10-02 11.94
2024-10-01 11.89
2024-09-30 11.97
2024-09-27 11.94
2024-09-26 11.92
2024-09-25 11.80
2024-09-24 11.83
2024-09-23 11.89
2024-09-20 11.83
2024-09-19 11.96
2024-09-18 11.98
2024-09-17 11.98
2024-09-16 12.04
2024-09-13 11.91
2024-09-12 11.94
2024-09-11 11.86
2024-09-10 11.82
2024-09-09 11.91
2024-09-06 11.82
2024-09-05 11.90
2024-09-04 11.98
2024-09-03 12.07
2024-08-30 12.07
2024-08-29 12.03
2024-08-28 11.94
2024-08-27 11.86
2024-08-26 11.88
2024-08-23 11.86
2024-08-22 11.82
2024-08-21 11.83
2024-08-20 11.70
2024-08-19 11.71
2024-08-16 11.73
2024-08-15 11.62
2024-08-14 11.63
2024-08-13 11.69
2024-08-12 11.67
2024-08-09 11.60
2024-08-08 11.64
2024-08-07 11.40
2024-08-06 11.45
2024-08-05 11.38